How many employees does Travere Therapeutics, Inc. have?

Travere Therapeutics, Inc. reported 497 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 19, 2026. That is up 29.1% from a year earlier.

What is Travere Therapeutics, Inc.'s revenue per employee?

Travere Therapeutics, Inc. brought in $491M of revenue in fiscal Dec 2025, which is $987K per employee. That ranks 17 of 46 companies we track in Biotechnology, where the median is $574K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Travere Therapeutics, Inc. employees and revenue per employee

TVTX · Biotechnology · $4.85B market cap

Travere Therapeutics, Inc. had 497 employees at the end of fiscal Dec 2025, up 29.1% from a year earlier. Revenue for the year was $491M, up 110.5% from a year earlier, or $987K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

497

+29.1% YoY

Revenue

$491M

+110.5% YoY

Revenue / employee

$987K

Peer median $574K

Rank in industry

17 of 46

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2016

Hover a year for the numbers.

TVTX employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	497	$491M	$987K	+29.1%	+110.5%
Dec 2024	385	$233M	$606K	+1.3%	+60.5%
Dec 2023	380	$145M	$382K	-17.7%	+32.7%
Dec 2022	462	$109M	$237K	+49.0%	-17.0%
Dec 2021	310	$132M	$425K	+18.3%	-33.5%
Dec 2020	262	$198M	$757K	+18.6%	+13.1%
Dec 2019	221	$175M	$793K	+3.3%	+6.8%
Dec 2018	214	$164M	$768K	+23.7%	+6.0%
Dec 2017	173	$155M	$896K	+28.1%	+16.0%
Dec 2016	135	$134M	$990K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Travere Therapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
TGTX TG Therapeutics, Inc.	399	$616M	$1.54M	Efficient growth
MIRM Mirum Pharmaceuticals, Inc.	369	$521M	$1.41M	Efficient growth
KRYS Krystal Biotech, Inc.	295	$389M	$1.32M	Efficient growth
TVTX Travere Therapeutics, Inc.	497	$491M	$987K	Efficient growth
ADMA ADMA Biologics, Inc.	647	$510M	$789K	Leaner
AXSM Axsome Therapeutics, Inc.	925	$638M	$690K	Efficient growth
BBIO BridgeBio Pharma, Inc.	834	$502M	$602K	Efficient growth
TWST Twist Bioscience Corporation	979	$377M	$385K	Efficient growth
INSM Insmed Incorporated	1,664	$606M	$364K	Efficient growth

Every Healthcare company

Questions about Travere Therapeutics, Inc.

How many employees does Travere Therapeutics, Inc. have?: Travere Therapeutics, Inc. reported 497 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 19, 2026. That is up 29.1% from a year earlier.
What is Travere Therapeutics, Inc.'s revenue per employee?: Travere Therapeutics, Inc. brought in $491M of revenue in fiscal Dec 2025, which is $987K per employee. That ranks 17 of 46 companies we track in Biotechnology, where the median is $574K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare TVTX with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Travere Therapeutics, Inc.'s annual reports (Form 10-K), latest filed February 19, 2026. This is data, not a recommendation to buy or sell TVTX.